Grace Therapeutics (L8S.F) Q2 2025 Earnings

23JunConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.36
-0.21
-0.06
0.09

Details

Expected EPS
-0.23909122500000002
Actual EPS
0.0947749
Surprise EPS
0.33
Surprise Percent
+139.64%

Description

Grace Therapeutics (L8S.F) has reported earnings of 0.0947749 per share for Q2 2025.

0 Comments

Share your thoughts